AGAP2 and prostate cancer: Reporter assays have identified the nucleotides -246/+36 in AGAP2 DNA sequence containing the minimal AGAP2 promoter region involved in AGAP2 expression in both chronic myeloid leukemia and prostate cancer human cell lines.